Zoonotic Disease Treatment Market

Zoonotic Disease Treatment Market: Drivers and Restraints

Increase in the global population growth, population mobility, and intense urbanization, may cause new zoonotic diseases to emerge in the future.  Populations in urban regions are unprotected to animal contact than rural populations, depending on the market structures and production systems of live food animals, but the urban population may also live in more teeming environments conducive to disease transmission. The growing demand for animal proteins leading to an increase in the consumption of animal fats is likely to contribute to the growth of zoonotic disease treatment market. For instance, global meat production is increased by nearly 2% per annum until 2015 and is likely to grow in the future. In addition, growing per-capita income of the individuals might drive a phenomenon known as “nutrition transition” that is change from a diet of rice, beans, and corn to one that incorporates more animal protein. This is likely to increase the diseases transmitted through zoonotic mode contributing to the growth of the zoonotic disease treatment market. However, lack of awareness about these diseases, the high investments required on research and development, and the high prices of the drugs might hamper the growth of zoonotic disease treatment market.    

Zoonotic Disease Treatment Market: Segmentation

The global zoonotic disease treatment market is broadly classified on the basis of disease type, causative agent, drug class and end user.                  

Zoonotic Disease Treatment Market: Overview

The global zoonotic disease treatmentmarket is expected to expand at healthy CAGR owing to the increasing consumption of animal fat across the world. Among end users, hospital end user segment is expected to account for maximum share due to requirement of advanced healthcare infrastructure and low cost.

Zoonotic Disease Treatment Market: Region-wise Outlook

Geographically, the global zoonotic disease treatment market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. Among all the regions, North America will continue to lead the global zoonotic disease treatment market. This is attributed to advanced healthcare infrastructure and increased healthcare spending in the region. Lack of proper sanitation facilities and lack of access to safe drinking water in many countries of Asia Pacific and Middle East & Africa might contribute to the increase in the spread of zoonotic diseases contributing to the growth of zoonotic disease treatment market.

Zoonotic Disease Treatment Market: Key Players

Key players operating in the global zoonotic disease treatment market include Novartis, Sanofi S.A., Johnson & Johnson, Pfizer, Inc., GlaxoSmithKline, AstraZeneca, F Hoffmann-La Roche Inc., and BioCryst Pharmaceuticals, Inc., among others.    

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, type of product and applications.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.